Jaime R. Merchan
- Obstetrics and Gynecology top 0.1%
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 20
- Immunology top 1%
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 22
- Cancer Immunotherapy and Biomarkers 19
-
- Renal cell carcinoma treatment 33
-
- Virus-based gene therapy research 22
-
- Bladder and Urothelial Cancer Treatments 19
- Urinary and Genital Oncology Studies 16
-
- Cancer Research and Treatments 17
- Co-authors
- Vikas P. SukhatmeS. Ananth KarumanchiJianyi LiIsaac E. StillmanTowia A. LibermannSharon E. MaynardFrank W. SellkeJames P. Morgan
- Journals
- JAMA (1 paper)Journal of Clinical Investigation (2 papers)Journal of Clinical Oncology (55 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Jaime R. Merchan
133 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Obstetrics and Gynecology 2.9k
- Pediatrics, Perinatology and Child Health 2.1k
- Cancer Research 1.5k
- Immunology 1.6k
- Oncology 1.9k
Countries citing papers authored by Jaime R. Merchan
This map shows the geographic impact of Jaime R. Merchan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime R. Merchan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime R. Merchan more than expected).
Fields of papers citing papers by Jaime R. Merchan
This network shows the impact of papers produced by Jaime R. Merchan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime R. Merchan. The network helps show where Jaime R. Merchan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jaime R. Merchan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 1 | |
| 8 | Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancerbreakdown → | 2022 | 163 |
| 9 | 2021 | 29 | |
| 10 | 2021 | 5 | |
| 11 | Initial results of the phase 1 portion of an ongoing phase 1/2 study of RP1 as a single agent and in combination with nivolumab in patients with solid tumors | 2019 | 1 |
| 12 | 2017 | 28 | |
| 13 | 2016 | 5 | |
| 14 | 2015 | 25 | |
| 15 | Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer. | 2014 | 14 |
| 16 | 2012 | 14 | |
| 17 | 2010 | 94 | |
| 18 | 2010 | 57 | |
| 19 | 2009 | 60 | |
| 20 | 2008 | 36 |
About Jaime R. Merchan
Jaime R. Merchan is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 140 papers that have together received 7.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (33 papers), Pancreatic and Hepatic Oncology Research (22 papers), Virus-based gene therapy research (22 papers), Cancer Genomics and Diagnostics (20 papers), Cancer Immunotherapy and Biomarkers (19 papers), Bladder and Urothelial Cancer Treatments (19 papers), Cancer Research and Treatments (17 papers) and Urinary and Genital Oncology Studies (16 papers). The work is most often cited by research in Obstetrics and Gynecology (2.9k citations), Pediatrics, Perinatology and Child Health (2.1k citations) and Cancer Research (1.5k citations). Jaime R. Merchan has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Vikas P. Sukhatme, S. Ananth Karumanchi, Jianyi Li, Isaac E. Stillman, Towia A. Libermann, Sharon E. Maynard, Frank W. Sellke, James P. Morgan, Susanta Mondal and Franklin H. Epstein. Their work appears in journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.